78 related articles for article (PubMed ID: 10635531)
21. Rational design of novel, potent small molecule pan-selectin antagonists.
Kranich R; Busemann AS; Bock D; Schroeter-Maas S; Beyer D; Heinemann B; Meyer M; Schierhorn K; Zahlten R; Wolff G; Aydt EM
J Med Chem; 2007 Mar; 50(6):1101-15. PubMed ID: 17302397
[TBL] [Abstract][Full Text] [Related]
22. Differential role of selectins in experimental colitis.
Sans M; Salas A; Soriano A; Prats N; Gironella M; Pizcueta P; Elena M; Anderson DC; Piqué JM; Panés J
Gastroenterology; 2001 Apr; 120(5):1162-72. PubMed ID: 11266380
[TBL] [Abstract][Full Text] [Related]
23. An E-selectin binding assay based on a polyacrylamide-type glycoconjugate.
Weitz-Schmidt G; Stokmaier D; Scheel G; Nifant'ev NE; Tuzikov AB; Bovin NV
Anal Biochem; 1996 Jul; 238(2):184-90. PubMed ID: 8660609
[TBL] [Abstract][Full Text] [Related]
24. Lack of functional P-selectin ligand exacerbates Salmonella serovar typhimurium infection.
Kum WW; Lee S; Grassl GA; Bidshahri R; Hsu K; Ziltener HJ; Finlay BB
J Immunol; 2009 May; 182(10):6550-61. PubMed ID: 19414810
[TBL] [Abstract][Full Text] [Related]
25. Selectins--potential pharmacological targets?
Kneuer C; Ehrhardt C; Radomski MW; Bakowsky U
Drug Discov Today; 2006 Nov; 11(21-22):1034-40. PubMed ID: 17055414
[TBL] [Abstract][Full Text] [Related]
26. BMS-190394, a selectin inhibitor, prevents rat cutaneous inflammatory reactions.
Todderud G; Nair X; Lee D; Alford J; Davern L; Stanley P; Bachand C; Lapointe P; Marinier A; Martel A; Menard M; Wright JJ; Bajorath J; Hollenbaugh D; Aruffo A; Tramposch KM
J Pharmacol Exp Ther; 1997 Sep; 282(3):1298-304. PubMed ID: 9316838
[TBL] [Abstract][Full Text] [Related]
27. Polymerized liposome assemblies: bifunctional macromolecular selectin inhibitors mimicking physiological selectin ligands.
Bruehl RE; Dasgupta F; Katsumoto TR; Tan JH; Bertozzi CR; Spevak W; Ahn DJ; Rosen SD; Nagy JO
Biochemistry; 2001 May; 40(20):5964-74. PubMed ID: 11352731
[TBL] [Abstract][Full Text] [Related]
28. A novel class of potent nonglycosidic and nonpeptidic pan-selectin inhibitors.
Ulbrich HK; Luxenburger A; Prech P; Eriksson EE; Soehnlein O; Rotzius P; Lindbom L; Dannhardt G
J Med Chem; 2006 Oct; 49(20):5988-99. PubMed ID: 17004713
[TBL] [Abstract][Full Text] [Related]
29. Fucoidan induces apoptosis of human HS-sultan cells accompanied by activation of caspase-3 and down-regulation of ERK pathways.
Aisa Y; Miyakawa Y; Nakazato T; Shibata H; Saito K; Ikeda Y; Kizaki M
Am J Hematol; 2005 Jan; 78(1):7-14. PubMed ID: 15609279
[TBL] [Abstract][Full Text] [Related]
30. Heparan sulfate and chondroitin sulfate proteoglycans inhibit E-selectin binding to endothelial cells.
Luo J; Kato M; Wang H; Bernfield M; Bischoff J
J Cell Biochem; 2001; 80(4):522-31. PubMed ID: 11169736
[TBL] [Abstract][Full Text] [Related]
31. Human milk oligosaccharides affect P-selectin binding capacities: in vitro investigation.
Schumacher G; Bendas G; Stahl B; Beermann C
Nutrition; 2006 Jun; 22(6):620-7. PubMed ID: 16533594
[TBL] [Abstract][Full Text] [Related]
32. Modular synthesis of multivalent glycoarchitectures and their unique selectin binding behavior.
Papp I; Dernedde J; Enders S; Haag R
Chem Commun (Camb); 2008 Nov; (44):5851-3. PubMed ID: 19009103
[TBL] [Abstract][Full Text] [Related]
33. Multivalent display of quinic acid based ligands for targeting E-selectin expressing cells.
Shamay Y; Paulin D; Ashkenasy G; David A
J Med Chem; 2009 Oct; 52(19):5906-15. PubMed ID: 19746918
[TBL] [Abstract][Full Text] [Related]
34. Anionic phospholipids bind to L-selectin (but not E-selectin) at a site distinct from the carbohydrate-binding site.
Malhotra R; Taylor NR; Bird MI
Biochem J; 1996 Feb; 314 ( Pt 1)(Pt 1):297-303. PubMed ID: 8660298
[TBL] [Abstract][Full Text] [Related]
35. Endothelial selectins regulate skin wound healing in cooperation with L-selectin and ICAM-1.
Yukami T; Hasegawa M; Matsushita Y; Fujita T; Matsushita T; Horikawa M; Komura K; Yanaba K; Hamaguchi Y; Nagaoka T; Ogawa F; Fujimoto M; Steeber DA; Tedder TF; Takehara K; Sato S
J Leukoc Biol; 2007 Sep; 82(3):519-31. PubMed ID: 17595378
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of selectin binding by colloidal gold with functionalized shells.
Dernedde J; Enders S; Reissig HU; Roskamp M; Schlecht S; Yekta S
Chem Commun (Camb); 2009 Feb; (8):932-4. PubMed ID: 19214320
[TBL] [Abstract][Full Text] [Related]
37. Acquisition of P-selectin binding activity by en bloc transfer of sulfo Le(x) trisaccharide to the cell surface: comparison to a sialyl Le(x) tetrasaccharide transferred on the cell surface.
Tsuboi S; Srivastava OP; Palcic MM; Hindsgaul O; Fukuda M
Arch Biochem Biophys; 2000 Feb; 374(1):100-6. PubMed ID: 10640402
[TBL] [Abstract][Full Text] [Related]
38. The anti-inflammatory effects of a selectin ligand mimetic, TBC-1269, are not a result of competitive inhibition of leukocyte rolling in vivo.
Hicks AE; Abbitt KB; Dodd P; Ridger VC; Hellewell PG; Norman KE
J Leukoc Biol; 2005 Jan; 77(1):59-66. PubMed ID: 15466915
[TBL] [Abstract][Full Text] [Related]
39. Sulfatides, L- and P-selectin ligands, exacerbate the intimal hyperplasia occurring after endothelial injury.
Shimazawa M; Kondo K; Hara H; Nakashima M; Umemura K
Eur J Pharmacol; 2005 Sep; 520(1-3):118-26. PubMed ID: 16185947
[TBL] [Abstract][Full Text] [Related]
40. A 28-kDa glycoprotein functions as a platelet ligand for P-selectin (CD62P).
Li L; Qian KX; Geng JG
Thromb Haemost; 2002 Apr; 87(4):706-11. PubMed ID: 12008955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
